Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01474811 · ClinicalTrials.gov registry record
HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network
A clinical trial of Hepatitis C, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 13,559
- Enrollment target
- 20
- Study locations
NCT01474811: Completed study of Hepatitis C, sponsored by University of North Carolina, Chapel Hill.
NCT01474811 is a study of Hepatitis C that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 13,559 participants, above the 1,762-participant average among 106 other Hepatitis C trials with a reported enrollment target (670% higher). The trial reports 20 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01474811, a study of Hepatitis C, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 13,559 participants
- Enrollment target
- 20
- Study locations
Study Summary
The primary purpose of the HCV-TARGET study is to establish a nationwide registry of patients undergoing treatment with antiviral therapies for chronic hepatitis C (HCV) at both academic and community practices.
Primary Outcome
The primary outcome measure is the occurence (yes or no) of SVR, defined as undetectable HCV RNA in serum at least 3 months after stopping therapy. Point estimates and confidence intervals will be calculated to describe the frequency of SVR in various sub-populations enrolled in HCV-TARGET.
Conditions Studied
Study Locations (20)
California
- Scripps - La Jolla
- UCSD Medical Center - San Diego
- UCSF/San Fran General Hospital - San Francisco
- Univ of California, San Francisco - San Francisco
Florida
- University of Florida - Gainesville
- University of Miami Miller School of Medicine - Miami
- Orlando Immunology Center - Orlando
Illinois
- Lake Shore Gastroenterology & Liver Disease Inst. - Chicago
- Northwestern University - Chicago
- University of Chicago - Chicago
District of Columbia
- Georgetown University - Washington D.C.
- Howard University - Washington D.C.
Georgia
- Atlanta Medical Center - Atlanta
- Emory University - Atlanta
Arizona
- Mayo Clinic AZ - Phoenix
Arkansas
- Liver Wellness Center - Little Rock
Colorado
- University of Colorado, Denver - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13,559 participants |
| Start Date | 2011-11 |
| Est. Completion | 2022-09-09 |
What the finished NCT01474811 record still lists
NCT01474811 is an observational study that tracks outcomes without assigning an intervention. Its 13,559 participants enrollment target places it among the larger protocols in the corpus, above the 1,762-participant average among 106 other Hepatitis C trials with a reported enrollment target (670% higher).
The record links to 1 condition, with Hepatitis C appearing as the primary indexed condition, and to 0 interventions.
NCT01474811 names 20 study sites across 11 states, led by California, Florida, Illinois.
Frequently Asked Questions
What is clinical trial NCT01474811 about?
NCT01474811 is a clinical study titled "HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network". The primary purpose of the HCV-TARGET study is to establish a nationwide registry of patients undergoing treatment with antiviral therapies for chronic hepatitis C (HCV) at both academic and community practices.
What is the current status of trial NCT01474811?
This trial is currently completed. The enrollment target is 13,559 participants. The study started on 2011-11. Estimated completion is 2022-09-09.
What conditions does trial NCT01474811 study?
This clinical trial studies the following conditions: Hepatitis C.
Who is sponsoring clinical trial NCT01474811?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01474811 being conducted?
This trial has 20 study locations across Arizona, Arkansas, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatitis C
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01474811's enrollment target sits among peer trials
13,559 2nd of 106 the highest of 106 other Hepatitis C trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hepatitis C trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
DBS TaT in Peer-assisted Telemedicine for Hepatitis C
RECRUITING · NA
-
Evaluation of Patients With Liver Disease
RECRUITING
-
The HOPE Study: Characterizing Patients With Hepatitis B and C
RECRUITING
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs
RECRUITING · NA
-
The Treatment in Pregnancy for Hepatitis C ("TiP-HepC") Registry
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05141396 · 13,400 participants · NA
Telehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH)
- NCT06058767 · 13,764 participants · NA
Preschool Hearing Screening
- NCT05991453 · 13,000 participants · NA
Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial
- NCT07177352 · 13,000 participants · Phase 3
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia